Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
This study has been completed.
Information provided by (Responsible Party):
First received: August 30, 2006
Last updated: November 3, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2007|
|Primary Completion Date:||June 2007 (Final data collection date for primary outcome measure)|